Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H24N2O3 |
Molecular Weight | 340.4162 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(N(CC2CC2)C(=O)NC1=O)C(=O)C3=CC(C)=CC(C)=C3
InChI
InChIKey=UCOAKFIVSAVHLC-UHFFFAOYSA-N
InChI=1S/C20H24N2O3/c1-11(2)16-17(18(23)15-8-12(3)7-13(4)9-15)22(10-14-5-6-14)20(25)21-19(16)24/h7-9,11,14H,5-6,10H2,1-4H3,(H,21,24,25)
Molecular Formula | C20H24N2O3 |
Molecular Weight | 340.4162 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
IQP-0528 is an antiretroviral pyrimidinedione derivative with activity against human immunodeficiency virus (HIV) in the nanomolar range. It is a non-nucleoside reverse transcriptase inhibitor that also inhibits HIV entry through an unknown mechanism thought to target a conformational epitope formed prior to the fusion of the viral envelope with the host cellular membrane. IQP-0528 is under clinical development for HIV prevention.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors. | 2007 |
|
Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents. | 2011 Dec |
|
Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides. | 2011 Nov |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11158731
IQP-0528 (SJ-3366) exhibited a Ki value of 3.2 nM, with a mixed mechanism of inhibition against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, but it did not inhibit HIV-2 reverse transcriptase. SJ-3366 also inhibited the entry of both HIV-1 and HIV-2 into target cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:02:45 GMT 2023
by
admin
on
Sat Dec 16 08:02:45 GMT 2023
|
Record UNII |
1Y42TZL33O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1367755-87-0
Created by
admin on Sat Dec 16 08:02:45 GMT 2023 , Edited by admin on Sat Dec 16 08:02:45 GMT 2023
|
SUPERSEDED | |||
|
1Y42TZL33O
Created by
admin on Sat Dec 16 08:02:45 GMT 2023 , Edited by admin on Sat Dec 16 08:02:45 GMT 2023
|
PRIMARY | |||
|
483499
Created by
admin on Sat Dec 16 08:02:45 GMT 2023 , Edited by admin on Sat Dec 16 08:02:45 GMT 2023
|
PRIMARY | |||
|
DB14888
Created by
admin on Sat Dec 16 08:02:45 GMT 2023 , Edited by admin on Sat Dec 16 08:02:45 GMT 2023
|
PRIMARY | |||
|
301297-45-0
Created by
admin on Sat Dec 16 08:02:45 GMT 2023 , Edited by admin on Sat Dec 16 08:02:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
EC50
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|